Menu

December 15, 2016, 12:00 pm – 1:30 pm CT / 1:00 pm – 2:30 pm ET

The Opioid Crisis:
An Update for Safety Leaders

Session Overview

The opioid crisis in America is breathtaking and demands our attention. Dr. Gladstone McDowell is a global leader in pain management who is the Medical Director of Integrated Pain Solutions. He is a trained specialist in Urology, Urologic Oncology, Anesthesiology, Pain Management, and Patient Safety. Dr. McDowell will address the current opioid crisis and updated numbers just reported by the DEA. He will address the issue of gateway drugs and how our healthcare staff, patients, and families are at risk. We will discuss the latest in drug diversion and what safety leaders need to know and watch for in 2017.

We offer these online webinars at no cost to our participants.

……………………………………………………………………………………………………..

Webinar Video, and Downloads

Webinar Video:

National Survey Results:

Click here to download the National Survey Results.

Speaker Slide Set:

Click here to download the combined speakers’ slide set in PDF format – one (1) slide per page.

To view the file, click the desired link (please note: the files may take several minutes to download). To save to your hard drive, right click on the link and choose “Save Target As.” (In some browsers it might say “Save Link As.”)

……………………………………………………………………………………………………..

Registration Information and CE Credit Information

Register: The webinar has previously taken place. See webinar video above.

Webinar date: December 15, 2016

Time:

  • 01:00 PM to 2:30 PM Eastern Daylight Time
  • 12:00 PM to 1:30 PM Central Daylight Time
  • 11:00 AM to 12:30 PM Mountain Daylight Time
  • 10:00 AM to 1:30 AM Pacific Daylight Time

We are accepting questions now that relate to the session topics. Please e-mail any questions related to the specific session to webinars@safetyleaders.org with the session title in the e-mail message header.

  • Questions about the Webinar series?
    E-mail webinars@safetyleaders.org or call 512-473-2370 between 9:00 a.m. and 4:30 p.m. CT.
  • Need technical assistance with registration? Call 512-457-7605 between 9:00 a.m. and 4:30 p.m. CT.


Learning Objectives:

  • Awareness: Participants will learn about the detail about the current explosion of deaths due to opioid overdoses.

  • Accountability: Participants will learn about the accountability issues for governance, administration, clinical, and patient safety leaders need to consider pertaining to opioid adverse events including drug diversion.
  • Ability: Participants will learn how to view the current opioid overdose crisis and issues pertaining to drug diversion.
  • Action: Participants will understand what actions they may need to take in light of the evidence based view of Opioid Overdose epidemics.

CE Participation Documentation

Texas Medical Institute of Technology, approved by the California Board of Registered Nursing, Provider Number 15996, will be issuing 1.5 contact hours for this webinar. TMIT is only providing nursing credit at this time.

To request a Participation Document, please click here.

……………………………………………………………………………………………………..

Session Speakers and Panelists

Gladstone C. McDowell, II, MD
Gladstone C. McDowell, II, MDThe Opioid Crisis: An Update for Safety Leaders
Bio
Gregory H. Botz, M.D., FCCM
Gregory H. Botz, M.D., FCCMDiscussion and Reaction to Presentations
Bio
Dan Ford, MBA, LFACHE
Dan Ford, MBA, LFACHE Discussion and Reaction to Presentation AND the Voice of Patient and Family
Bio
C. R. Denham, II, MD
C. R. Denham, II, MDIn the News and Recent Polling
Bio

Related Resources

  1. Villapiano NLG MD MSc, Winkelman TNA MD MSc, et al. Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013. JAMA Pediatrics Research Letter. 2016 Dec 12. Available at http://jamanetwork.com/journals/jamapediatrics/fullarticle/2592302.   
  2. Burger G, Burger M. Drug Diversion: New Approaches to an Old Problem. American Journal of Pharmacy Benefits. 2016 Jan/Feb.Available at http://www.ajpb.com/journals/ajpb/2016/ajpb_januaryfebruary2016/drug-diversion-new-approaches-to-an-old-problem.   
  3. Ingram C. Heroin deaths surpass gun homicides for the first time, CDC data shows. The Washington Post website. 2016 Dec 8. Available at https://www.washingtonpost.com/news/wonk/wp/2016/12/08/heroin-deaths-surpass-gun-homicides-for-the-first-time-cdc-data-show/?utm_term=.e56841d08fa9.   
  4. Morabito N. Local nurses keep their licenses for more than a year after drug diversion first suspected. News Channel WJHL website (ABC affiliate). 2016 Dec 8. Available at http://wjhl.com/2016/12/08/local-nurses-keep-their-licenses-for-more-than-a-year-after-drug-diversion-first-suspected/.   
  5. DEA. 2016 National Drug Threat Assessment Summary. Department of Justice. November 2016. Available at https://www.dea.gov/resource-center/2016%20NDTA%20Summary.pdf.   
  6. Cote L. DEA Decisions: Evidence of “Red Flags” of Drug Diversion. DEA Chronicles. 2016 Nov 13. Available at http://deachronicles.quarles.com/2016/11/dea-decisions-evidence-of-red-flags-of-drug-diversion/.   
  7. Gupta R, Shah N, et al. The Rising Price of Naloxone — Risks to Efforts to Stem Overdose Deaths. The NEJM. 2016 Dec 8. Available at http://www.nejm.org/doi/full/10.1056/NEJMp1609578?af=R&rss=currentIssue#t=article.   
  8. Editorial Board. Painkiller abuses and ignorance. The New York Times March 2, 2015:A18. Available at http://www.nytimes.com/2015/03/02/opinion/painkiller-abuses-and-ignorance.html.   
  9. Frenk SM, Porter KS, Paulozzi LJ. Prescription opioid analgesic use among adults: United States, 1999-2012. NCHS Data Brief. 2015 Feb;(189):1-8. Available at http://www.cdc.gov/nchs/data/databriefs/db189.pdf.   
  10. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med2011 Nov 24;365(21):2002-12. Available at http://www.nejm.org/doi/pdf/10.1056/NEJMsa1103053.   
  11. Haffajee RL, Jena AB, Weiner SG. Mandatory use of prescription drug monitoring programs. JAMA 2015 Mar 3;313(9):891-2. Available at http://jama.jamanetwork.com/article.aspx?articleid=2107540.   
  12. Islam MM, McRae IS. An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions. BMC Pharmacol Toxicol 2014 Aug 16;15:46. Available at http://www.biomedcentral.com/content/pdf/2050-6511-15-46.pdf.   
  13. McPherson ML. Strategies for the management of opioid-induced adverse effects. University of Tennessee Advanced Studies in Pharmacy 2008 Jun;5(2):52-7. Available at http://www.utasip.com/files/articlefiles/pdf/3rd%20article.pdf.   
  14. [No authors listed.] Safe use of opioids in hospitals. Sentinel Event Alert Issue 49. Oakbrook Terrace (IL): The Joint Commission; 2012 Aug 8. Available at http://www.jointcommission.org/assets/1/18/SEA_49_opioids_8_2_12_final.pdf.   
  15. Warner M, Hedegaard H, Chen L-H. Trends in drug-poisoning deaths involving opioid analgesics and heroin: United States, 1999-2012. NCHS Health E-Stat. Atlanta (GA): Centers for Disease Control and Prevention; 2014 Dec 2. Available athttp://www.cdc.gov/nchs/data/hestat/drug_poisoning/drug_poisoning_deaths_1999-2012.pdf.   
  16. Yokell MA, Delgado MK, Zaller ND, et al. Presentation of prescription and nonprescription opioid overdoses to US emergency departments. JAMA Intern Med 2014 Dec;174(12):2034-7. Available at http://archinte.jamanetwork.com/article.aspx?articleid=1918924.   
  17. IOM (Institute of Medicine). Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Report Brief. Washington, DC: The National Academies Press; 2011 Jun. Available athttp://www.iom.edu/~/media/Files/Report%20Files/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research/Pain%20Research%202011%20Report%20Brief.pdf.   
  18. IOM (Institute of Medicine). Committee on Advancing Pain Research, Care, and Education; Board on Health Sciences Policy. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press; 2011 Jun. Available at http://www.nap.edu/catalog.php?record_id=13172.   
  19. U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. National Action Plan for Adverse Drug Event Prevention. Washington, DC: U.S. Department of Health and Human Services; 2014. Available at http://www.health.gov/hai/pdfs/ADE-Action-Plan-508c.pdf.   
  20. AHRQ. Efforts to improve patient safety result in 1.3 million fewer patient harms: Interim update on 2013 annual hospital-acquired condition rate and estimates of cost savings and deaths averted from 2010 to 2013. Rockville (MD): Agency for Healthcare Research and Quality; 2014 Dec. Available at http://www.ahrq.gov/professionals/quality-patient-safety/pfp/interimhacrate2013.html.   
  21. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med 2015 Feb 17;162(4):276-86. Available at http://annals.org/data/Journals/AIM/932765/0000605-201502170-00006.pdf.   
  22. National Quality Forum. Safe Practice 1: Culture of Safety Leadership Structures and Systems. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org.   
  23. National Quality Forum. Safe Practice 2: Culture Measurement, Feedback, and Intervention. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at
    http://www.qualityforum.org
  24. National Quality Forum. Safe Practice 3: Teamwork Training and Skill Building. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at
    http://www.qualityforum.org
  25. National Quality Forum. Safe Practice 4: Risks and Hazards. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at
    http://www.qualityforum.org
  26. National Quality Forum. Safe Practice 18: Pharmacist Leadership Structures and Systems. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org.   
  27. National Quality Forum. Chapter 9: Opportunities for Patient and Family Involvement. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at
    http://www.qualityforum.org